1174297

Gregg H. Lucksinger, MD — FEI 3010609607

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 7, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cedar Park, TX (United States)

Additional Details

Clinical Investigator (CI)